Pictet Asset Management Holding SA »

Neurocrine Biosciences shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $149M 1.1M 137.91

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Jpmorgan Chase & Co
Morgan Stanley
Bellevue Group
T. Rowe Price Associates
Geode Capital Management
Henderson Group
Dodge & Cox
Wellington Management Company
DSM Capital Partners
Brown Advisory Holdings Incorporated
Pictet Asset Management Holding SA
Rock Springs Capital Management
Armistice Capital

View all funds holding Neurocrine Biosciences